Connection

FRANCESCO DEMAYO to Pancreas

This is a "connection" page, showing publications FRANCESCO DEMAYO has written about Pancreas.
Connection Strength

0.149
  1. Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model. Pancreas. 2003 Apr; 26(3):e67-73.
    View in: PubMed
    Score: 0.047
  2. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 1997 Sep 15; 11(18):2323-34.
    View in: PubMed
    Score: 0.032
  3. PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. PLoS One. 2012; 7(8):e40452.
    View in: PubMed
    Score: 0.023
  4. Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas. World J Surg. 2009 Apr; 33(4):630-7.
    View in: PubMed
    Score: 0.018
  5. Sulfonylurea receptor knockout causes glucose intolerance in mice that is not alleviated by concomitant somatostatin subtype receptor 5 knockout. Ann Surg. 2002 Jun; 235(6):767-74.
    View in: PubMed
    Score: 0.011
  6. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice. J Surg Res. 1999 Jun 15; 84(2):199-203.
    View in: PubMed
    Score: 0.009
  7. Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner. Int J Pancreatol. 1999 Jun; 25(3):157-63.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.